Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INNOVATIVE SOLUTIONS & SUPPORT INC Director's Dealing 2025

Apr 3, 2025

33638_dirs_2025-04-02_12a45311-98bc-4738-8541-a0d3178c430f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC)
CIK: 0000836690
Period of Report: 2025-02-18

Reporting Person: Askarpour Shahram (CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-18 Restricted Stock Units A 37835 $0.00 Acquired 370317 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-18 Non-Qualified Stock Option (Right to Buy) $9.88 A 72062 Acquired 2035-02-18 Common Stock (72062) Direct

Footnotes

F1: The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. The number of RSUs is based on the methodology determined by the Company's compensation committee prior to the date of grant on February 18, 2025. The grant was confirmed by the Company's board of directors on April 1, 2025. Each RSU represents the right to receive one share of Common Stock, subject to adjustment as provided in the Award Agreement. The RSUs are scheduled to vest in accordance with the following schedule: 1/4th on the first anniversary of the grant date and 1/12th on each quarterly anniversary of the grant date thereafter, subject to continued employment by the reporting person.

F2: The non-qualified stock option was granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. The number of shares of Common Stock underlying the option is based on the methodology determined by the Company's compensation committee prior to the date of grant on February 18, 2025. The grant was confirmed by the Company's board of directors on April 1, 2025. The option is scheduled to vest in accordance with the following schedule: 1/4th on the first anniversary of the grant date and 1/12th on each quarterly anniversary of the grant date thereafter, subject to continued employment by the reporting person. The option becomes exercisable, if at all, if the price of the Company's common stock on the Nasdaq Stock Market is equal to or greater than $9.8785 for 20 consecutive trading days during the vesting period of the option.